About admin


Students hear ‘wake-up call’ about tobacco

Source: Star-Tribune Writer: ALLISON RUPP Gruen Von Behrens' story brought some middle-schoolers to tears. If it didn't bring tears, it at least had them asking questions and thinking about the negative effects of tobacco. During the question and answer part of Von Behrens' presentation, one girl's voice trembled as she asked, "How long does it take someone to die from tobacco?" Von Behrens doesn't care if he scares students. In fact, that's what he wants. "Some of the things may scare you," he said in the beginning. "If scaring you is what keeps you from using tobacco products, then I am going to scare the pants off you." Von Behrens didn't even need to open his mouth for some fear to set in. He has undergone 34 surgeries and hundreds of procedures to remove oral cancer from his mouth and repair what was left over. His face prominently shows what chewing tobacco can do. The 31-year-old lost all his teeth, most of his tongue and his jaw, although part of a leg bone was used to replace the jaw. Layers of skin from his thigh were used to try to rebuild his chin. Von Behrens began chewing tobacco at 13. Students and teachers called the presentation "powerful." "My parents don't smoke, do drugs or really drink alcohol so I always knew I didn't really want to do that stuff," said Levi Shade, an eighth-grader at Poison Spider School. "But now it's a sure thing -- I will never ever do it." Von [...]

2009-02-17T12:35:17-07:00February, 2009|Oral Cancer News|

Row erupts over oral cancer paper authorship

Source:The Australian Writer: Gay Healy AN international expert on oral cancer withdrew from joint authorship of a paper that drew a link between the disease and theListerine mouthwash made by his university laboratory's corporate sponsors, it has been claimed. The research paper's co-authors say Newell Johnson, whose Griffith University laboratory was funded by pharmaceutical firm Pfizer, Listerine's recent owner, decided not to put his name to the research paper, which made headlines across the world with its finding that alcohol-based mouthwashes were implicated in oral cancer. Professor Johnson says he was never an author. The claim about his involvement and withdrawal, made by Australian co-authors Michael McCullough of the University of Melbourne and Camile Farah of the University of Queensland, adds a new dimension to the controversy ignited by the paper, published in the Australian Dental Journal last December. In January UQ's head of dentistry Laurence Walsh came to the defence of mouthwashes, arguing they might prevent oral cancer, but later conceded that Listerine's present owner, Johnson & Johnson, had sponsored some of his workshops. The paper found the risk of oral cancer was increased by prolonged use of alcohol-based mouthwashes and highlighted six Listerine products. Professor McCullough said the research paper or literature review sprang from a 2007 meeting of the three researchers at a conference in Amsterdam. "After a session on the role of alcohol in oral cancer, we ended up deciding that we would formally write this article and review it between the three of us," hesaid. [...]

2009-02-17T12:18:31-07:00February, 2009|Oral Cancer News|

Dental Calamities That Can Truly Hurt

Source: New York Times Writer: Nicholas Bakalar DENTAL cavities are not good news, but when it comes to preventive oral health, they may be among the smaller problems. The advice is familiar: brush and floss regularly, use fluoride mouthwash, limit snacks and sweet drinks, visit the dentist twice a year. Good suggestions, even if not everyone follows them: by age 12, 50 percent of children have cavities. But there are two much more serious problems, common dental diseases that can lead not only to loss of teeth but also to loss of life: periodontal disease and oral cancer. Periodontal disease — a chronic bacterial infection of the gums that destroys the bone and tissues that hold the teeth — is the leading cause of tooth loss in adults. Some people are genetically susceptible, and the problem can be aggravated by smoking, taking certain medications, stress and other factors. Several studies have found that gum disease is associated with an increased risk for heart attack. “It isn’t nailed down yet,” said Dr. Martin J. Davis, professor of clinical dentistryat the College of Dental Medicine at Columbia, “but there seems to be a link between the inflammation of gums and the inflammatory markers of heart disease.” It may be that oral bacteria enter the bloodstream, attach to fatty plaques in the coronary arteries and cause clots to form. Or maybe inflammation itself increases plaque buildup. A 2007 study showed that periodontal disease increased the risk of heart disease in men by one third and doubled it in women, even [...]

2009-02-17T09:56:09-07:00February, 2009|Oral Cancer News|

Visual Screening for Oral Cancer is Cost Effective in Low-Income Countries

Source: Carolina News Wire Writer: Lisa Bistreich, Patrick Gibbons RESEARCH TRIANGLE PARK, N.C. — Using visual inspection to screen for oral cancer is a cost-effective approach to earlier diagnosis in low- and middle-income countries, according to a study conducted by researchers at RTI International.  The study, published in the Bulletin of the World Health Organization, looked at health care workers in Southern India, where oral cancer is a major health problem, and found that visual oral screening, particularly among high-risk individuals is cost-effective. "Our results show that screening for oral cancers by visual inspection is comparable or less expensive than the more widely accepted practice of screening for cervical cancers," said lead author Sujha Subramanian, a senior health economist at RTI. "We hope that the findings of this study will increase screening for oral cancers and help reduce the devastating impact of this cancer on families." More than 160,000 people participated in the study, and the researchers found that targeted screening of the high-risk group of alcohol and tobacco users is the most cost-effective approach. They determined that visual inspection for oral cancer targeted to high-risk people could be performed for under $6 per person over the course of a nine-year screening program.  According to GLOBOCAN, the Indian subcontinent alone accounts for one-third of the world burden and oral cancer is the most common form of cancer and cancer-related death among men in India. Two-thirds of all deaths from oral cancers occur in low income countries. Worldwide, 270,000 new cases and 145,000 [...]

2009-02-12T16:14:33-07:00February, 2009|Oral Cancer News|

Gwyneth Paltrow: Charity Chick

Source: Gossipgirls.com She’s always been interested in using her celebrity for the benefit of others, and last night Gwyneth Paltrow was spotted at the Women’s Cancer Research Fund’s ‘Unforgettable Evening.’ The “Shakespeare in Love” hottie was looking absolutely gorgeous as she arrived at the Beverly Wilshire Hotel, sporting a white dress with a matching blazer and a pair of pink and yellow feathered heels as she mingled with guests including Courtney Cox and Rita Wilson. And Gwyn was more than just another attendee at the event - she also received the 2009 Courage Award for her dedication to cancer research. Gwyneth, along with her mother Blythe Danner and brother Jake Paltrow founded the Bruce Paltrow Oral Cancer Fund in memory of her father who suffered for years with mouth cancer, and finally lost his battle in 2002. The fund is part of the National non-profit Oral Cancer Foundation, (http://www.oralcancer.org)

2009-02-13T00:43:23-07:00February, 2009|Oral Cancer News|

Gwyneth Paltrow & More At Cancer Benefit Tuesday In LA

Source: LA News Reporter: Access Hollywood Tonight in LA for a cancer benefit, honorees Gwyneth Paltrow and Courteney Cox will join Jennifer Aniston, David Arquette, Sheryl Crow, Lisa Kudrow, Laura Dern, Jennifer Meyer and Tobey Maguire, Angie Harmon and Jason Sehorn, Josh Groban, Lisa Rinna and Harry Hamlin, Kirk and Anne Douglas, Jessica Capshaw, along with the Entertainment Industry Foundation’s (EIF’s) Women’s Cancer Research Fund (WCRF) honorary chairs Rita Wilson and Tom Hanks, and Kate Capshaw and Steven Spielberg. Also attending are EIF’s WCRF co-founders Kelly Chapman Meyer, Jamie Tisch, Anne Douglas, Quinn Ezralow, Marion Laurie, and Saks Fifth Avenue Beverly Hills’ Vice President & General Manager Larry Bruce. The event, at the Beverly Wilshire Hotel in Beverly Hills, will feature a performance by Beyonce. The 14th Annual Saks Fifth Avenue’s Unforgettable Evening benefiting the Entertainment Industry Foundation’s Women’s Cancer Research Fund (EIF’s WCRF), raises much needed funds each year for innovative cancer research, and recognizes one remarkable individual for his or her unwavering commitment to the cause. Oscar winner Gwyneth Paltrow will receive the 2009 Courage Award. She, along with her mother, Blythe Danner, and brother, Jake Paltrow, established the Bruce Paltrow Fund in memory of her father who lived with oral cancer for several years. The Bruce Paltrow Fund, set up through The Oral Cancer Foundation and with support from the EIF, works to prevent oral cancer through public education, early detection and patient support. In 2008, Paltrow served as ambassador for EIF and Saks Fifth Avenue’s KEY TO THE CURE Initiative, appearing in a [...]

2009-02-11T14:09:48-07:00February, 2009|Oral Cancer News|

Smokeless tobacco ups oral cancer risk 80 pct – WHO

Source: in.reuters.com Author: staff Chewing tobacco and snuff are less dangerous than cigarettes but the smokeless products still raise the risk of oral cancer by 80 percent, the World Health Organisation's cancer agency said on Tuesday. The review of 11 studies worldwide showed people who chewed tobacco and used snuff also had a 60 percent higher risk of oesophagus and pancreatic cancer. The researchers sought to quantify the risk of smokeless tobacco after a number of studies differed on just how dangerous the products were, said Paolo Boffetta, an epidemiologist at the WHO's International Agency for Research on Cancer. "What we did was try to quantify the burden of smokeless cancer," he said in a telephone interview. "This has never been attempted in such a systematic way before." The researchers, who published their findings in Lancet Oncology, did this by looking at population-wide studies and trials of both humans and animals. They found frequency of use varies greatly both across and within countries, depending on sex, age, ethnic origin and economic background, and were highest in the United States, Sweden and India. They also found that while snuff and chew were less dangerous than smoking because they were not linked to lung cancer, getting cigarette users to switch was not good public policy. "If all smokers did this there would be a net benefit," Boffetta said. "The point is we don't know whether this would happen and there is no data to suggest these smokers would stop or switch."

2009-01-28T15:29:47-07:00January, 2009|Oral Cancer News|

Nicorette launches 25g nicotine patch to help people stop smoking

Source: Nursing Times Nicorette has launched a new nicotine replacement therapy programme that includes a 25mg nicotine patch to help people trying to stop smoking Nicorette recommends that smokers begin a stop smoking attempt using a 25mg nicotine patch for eight weeks, then step down to a 15mg patch for two weeks, followed by 10mg patch for a further two weeks. They cite evidence from a European multi-centre trialinvolving 3,575 smokers to support the introduction of a higher strength 25mg patch. This study found that one in two smokers who used the 25mg patch and abstained from smoking during the first week of a quit attempt remained smoke free at 12 weeks. Read full study here

2009-01-26T13:21:16-07:00January, 2009|Oral Cancer News|

Developing smokeless tobacco products for smokers: an examination of tobacco industry documents : February 2009 (Volume 18, Number 1)

Source: Clove Cigarettes News Blog  Objective: To investigate whether development of smokeless tobacco products (SLT) is intended to target current smokers. . . . Conclusions: Heavy marketing of new SLT products may encourage dual use and result in unknown public health effects. SLT products have been designed to augment cigarette use and offset regulatory strategies such as clean indoor air laws. In the United States, the SLT strategy may provide cigarette companies with a diversified range of products under the prospect of federal regulation. These products may pose significant challenges to efforts by federal agencies to reduce harm caused by tobacco use. Internal documents show that tobacco manufacturers, including cigarette and SLT companies, have developed and targeted new SLT products to exploit cigarette smokers. Cigarette manufacturers recognised the importance of entering the SLT market especially in light of health, social and legislative changes influencing the cigarette market and shifting demographics of traditional SLT users. Cigarette manufacturers were initially focused on developing alternative smokeless products for smokers who would otherwise quit because of the changes in the cigarette market. Over time, the cigarette companies appear to have focused their efforts on products designed to augment cigarette use when smoking is not possible, thus offsetting regulatory strategies such as clean indoor air laws. Major cigarette companies’ marketing of new SLT products under established brand names may be aimed at increasing the appeal of SLT to smokers, who are not necessarily interested in quitting smoking. At the same time, SLT companies have aimed [...]

2009-01-26T13:07:36-07:00January, 2009|Oral Cancer News|

Smoking Behaviors Among Cancer Survivors: An Observational Clinical Study

Source: Journal of Oncology Practice Author:Lola Burke, MSI, Lesley-Ann Miller, PhD, MS, Ayman Saad, MD, Jame Abraham, MD Purpose: Smoking is a well-recognized risk factor for several cancers including cancers of the lung, bladder, and head and neck. Studies have shown that smoking can adversely affect the outcomes of different modalities of cancer treatment. This study examines smoking behaviors among cancer survivors to collect information necessary to create successful smoking cessation interventions. Methods: For this observational clinical study, questionnaires were sent to 1,000 randomly selected patients diagnosed with cancer between 2003 and 2007 in one cancer center. Data were statistically analyzed to determine the likelihood of a patient quitting smoking after being diagnosed with cancer. Results: We received 187 responses from the 1,000 surveys sent (18.7%). Of these, 166 were usable for analysis. The mean age of respondents was 64 (± 13) years. Men were more likely than women to be past smokers (55% of men and 32% of women respectively, P = .003). Fifty-two percent of respondents reported having a history of smoking. However, only 20% of patients reported having been active smokers at the time they were diagnosed with cancer. Furthermore, only 44% of these reported having quit smoking after their diagnosis with cancer. Only 62% of all respondents reported that they had been informed of the dangers of smoking by their health care provider during cancer treatment. Conclusion: In our study sample, less than one half (44%) of smoking cancer patients quit smoking after their cancer diagnosis, and only 62% of smoking cancer patients received smoking cessation counseling from their physicians. Intervention programs are needed to help cancer survivors to quit smoking. Prospective clinical [...]

2009-04-07T18:27:23-07:00January, 2009|Oral Cancer News|
Go to Top